TY - JOUR
T1 - Therapeutic Mastoidectomy Does Not Increase Postoperative Complications in the Management of the Chronic Ear
AU - Shew, Matthew A.
AU - Muelleman, Thomas
AU - Villwock, Mark
AU - Muelleman, Robert J.
AU - Sykes, Kevin
AU - Staecker, Hinrich
AU - Lin, James L.
N1 - Publisher Copyright:
© 2017, Otology & Neurotology, Inc.
PY - 2018/1/1
Y1 - 2018/1/1
N2 - Objective: Tympanoplasty with or without concurrent therapeutic mastoidectomy is a controversial topic in the management of chronic ear disease. We sought to describe whether there is a significant difference in postoperative complications. Study Design: Retrospective cohort study. Setting: American College of Surgeons National Surgical Quality Improvement Program public files. Patients: Current procedural terminology codes were used to identify patients with chronic ear disease undergoing tympanoplasty ± concurrent mastoidectomy in the 2011 to 14 American College of Surgeons National Surgical Quality Improvement Program files. Intervention: Therapeutic. Main Outcome Measures: Variables were compared with χ 2, Fischer's exact, and Mann-Whitney U tests, as appropriate to analyze postoperative complications between tympanoplasty with or without concurrent mastoidectomy. To account for confounding factors, presence of a complication was analyzed in binary logistic regression. Analysis considered sex, hypertension, obesity, advanced age, diabetes, smoking status, American Society of Anesthesiologists Physical status, procedure. Results: There were 4,087 patients identified meeting criteria (tympanoplasty = 2,798, tympanomastoidectomy = 1,289). There was no statistical difference in postoperative complications (tympanoplasty n = 49 [1. 8%], tympanomastoidectomy n = 33 [2. 6%]; p = 0. 087) or return to the operating room (tympanoplasty = 4 [0. 1%], tympanomastoidectomy = 6 [0. 5%]; p = 0. 082). Binary logistic regression demonstrated smoking as a predictor of a postoperative complication (OR: 1. 758, 95% CI: 1. 084-2. 851; p = 0. 022), while concurrent mastoidectomy did not significantly increase the risk of complication (OR: 1. 440, 95% CI: 0. 915-2. 268; p = 0. 115). There was a significant difference in mean operative time between tympanoplasty and tympanomastoidectomy: 85.7 versus 154.23 min, p < 0. 001. Conclusion: In the management of chronic ear disease, tympanoplasty with concurrent mastoidectomy increases time under anesthesia, but it is not associated with any increased postoperative complications compared with tympanoplasty alone.
AB - Objective: Tympanoplasty with or without concurrent therapeutic mastoidectomy is a controversial topic in the management of chronic ear disease. We sought to describe whether there is a significant difference in postoperative complications. Study Design: Retrospective cohort study. Setting: American College of Surgeons National Surgical Quality Improvement Program public files. Patients: Current procedural terminology codes were used to identify patients with chronic ear disease undergoing tympanoplasty ± concurrent mastoidectomy in the 2011 to 14 American College of Surgeons National Surgical Quality Improvement Program files. Intervention: Therapeutic. Main Outcome Measures: Variables were compared with χ 2, Fischer's exact, and Mann-Whitney U tests, as appropriate to analyze postoperative complications between tympanoplasty with or without concurrent mastoidectomy. To account for confounding factors, presence of a complication was analyzed in binary logistic regression. Analysis considered sex, hypertension, obesity, advanced age, diabetes, smoking status, American Society of Anesthesiologists Physical status, procedure. Results: There were 4,087 patients identified meeting criteria (tympanoplasty = 2,798, tympanomastoidectomy = 1,289). There was no statistical difference in postoperative complications (tympanoplasty n = 49 [1. 8%], tympanomastoidectomy n = 33 [2. 6%]; p = 0. 087) or return to the operating room (tympanoplasty = 4 [0. 1%], tympanomastoidectomy = 6 [0. 5%]; p = 0. 082). Binary logistic regression demonstrated smoking as a predictor of a postoperative complication (OR: 1. 758, 95% CI: 1. 084-2. 851; p = 0. 022), while concurrent mastoidectomy did not significantly increase the risk of complication (OR: 1. 440, 95% CI: 0. 915-2. 268; p = 0. 115). There was a significant difference in mean operative time between tympanoplasty and tympanomastoidectomy: 85.7 versus 154.23 min, p < 0. 001. Conclusion: In the management of chronic ear disease, tympanoplasty with concurrent mastoidectomy increases time under anesthesia, but it is not associated with any increased postoperative complications compared with tympanoplasty alone.
KW - Chronic ear disease
KW - Complications
KW - Mastoidectomy
KW - Tympanoplasty
UR - http://www.scopus.com/inward/record.url?scp=85039449834&partnerID=8YFLogxK
U2 - 10.1097/MAO.0000000000001609
DO - 10.1097/MAO.0000000000001609
M3 - Article
C2 - 29076928
AN - SCOPUS:85039449834
SN - 1531-7129
VL - 39
SP - 54
EP - 58
JO - Otology and Neurotology
JF - Otology and Neurotology
IS - 1
ER -